PTCG
PFE icon

Pring Turner Capital Group’s Pfizer PFE Stock Holding History

Pring Turner Capital Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-88,882
Closed -$2.71M – 52
2014
Q1 		$2.71M Buy
88,882
+28,621
+47% +$853K 2.54% 23
2013
Q4 		$1.75M Buy
+60,261
New +$1.75M 1.73% 24

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Pring Turner Capital Group's PFE Position: Q2 2014 in Review

Pring Turner Capital Group sold out of Pfizer (PFE) in Q2 2014, closing a stake of 88,882 shares — an estimated $2.71M sold.

Pring Turner Capital Group first reported a position in PFE in Q4 2013 and held it in 2 quarters. The position peaked at $2.71M in Q1 2014. 1,747 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

  • Pring Turner Capital Group reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
  • Pring Turner Capital Group sold 88,882 Pfizer shares in Q2 2014, an estimated $2.71M.
  • Pring Turner Capital Group first reported a position in Pfizer in Q4 2013 and held it in 2 quarters.
  • Pring Turner Capital Group's Pfizer position peaked at $2.71M in Q1 2014.
  • 1,747 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Pring Turner Capital Group's 13F filing for Q2 2014, filed 7 Aug 2014.